- Home
- PALI vs NCV Comparison
PALI vs NCV Comparison
Compare PALI & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PALI | NCV |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 373.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PALI | NCV |
|---|---|---|
| Price | $1.91 | $16.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.29 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 88.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.48% |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $14.27 |
| 52 Week High | $2.86 | $17.65 |
Technical Indicators
Market Signals| Indicator | PALI | NCV |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 43.82 |
| Support Level | $1.80 | $16.30 |
| Resistance Level | $2.19 | $16.67 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 9.72 | 46.39 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.